Stalevo is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Carbidopa; Levodopa; Entacapone.
Product ID | 0078-0408_1cae6786-12ca-4130-b059-38ca82bc1880 |
NDC | 0078-0408 |
Product Type | Human Prescription Drug |
Proprietary Name | Stalevo |
Generic Name | Carbidopa, Levodopa, And Entacapone |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2003-06-11 |
Marketing Category | NDA / NDA |
Application Number | NDA021485 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | CARBIDOPA; LEVODOPA; ENTACAPONE |
Active Ingredient Strength | 25 mg/1; mg/1; mg/1 |
Pharm Classes | Aromatic Amino Acid [EPC],Amino Acids, Aromatic [CS],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2003-06-11 |
Marketing End Date | 2021-08-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021485 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2003-06-11 |
Marketing End Date | 2014-08-04 |
Marketing Category | NDA |
Application Number | NDA021485 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2003-06-11 |
Ingredient | Strength |
---|---|
CARBIDOPA | 25 mg/1 |
SPL SET ID: | 5edfc3e7-f80d-47ee-897a-c02ff4eb3e74 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0407 | Stalevo | carbidopa, levodopa, and entacapone |
0078-0408 | Stalevo | carbidopa, levodopa, and entacapone |
0078-0409 | Stalevo | carbidopa, levodopa, and entacapone |
0078-0527 | Stalevo | carbidopa, levodopa, and entacapone |
0078-0544 | Stalevo | carbidopa, levodopa, and entacapone |
0078-0545 | Stalevo | carbidopa, levodopa, and entacapone |
52427-805 | Stalevo | carbidopa, levodopa, and entacapone |
52427-809 | Stalevo | carbidopa, levodopa, and entacapone |
52427-816 | Stalevo | carbidopa, levodopa, and entacapone |
52427-827 | Stalevo | carbidopa, levodopa, and entacapone |
52427-834 | Stalevo | carbidopa, levodopa, and entacapone |
52427-842 | Stalevo | Stalevo |
0781-5613 | Carbidopa, Levodopa, and Entacapone | Carbidopa, Levodopa, and Entacapone |
0781-5625 | Carbidopa, Levodopa, and Entacapone | Carbidopa, Levodopa, and Entacapone |
0781-5637 | Carbidopa, Levodopa, and Entacapone | Carbidopa, Levodopa, and Entacapone |
0781-5641 | Carbidopa, Levodopa, and Entacapone | Carbidopa, Levodopa, and Entacapone |
0781-5654 | Carbidopa, Levodopa, and Entacapone | Carbidopa, Levodopa, and Entacapone |
0781-5669 | Carbidopa, Levodopa, and Entacapone | Carbidopa, Levodopa, and Entacapone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
STALEVO 76431957 2799827 Live/Registered |
Orion Corporation 2002-07-16 |